// App-Quantinova.ai

11593 : Genomic alterations in 670 patients with diverse cancers analyzed by next-generation sequencing (NGS) of circulating tumor DNA (ctDNA).

Researchers

Presenter

  • Maria Clemence Schwaederle

Principal Investigators

  • Ranajoy Chattopadhyay

  • Shumei Kato

  • Paul T. Fanta

  • Kimberly Banks

  • David Eric Piccioni

  • Sadakatsu Ikeda

  • Amirali Talasaz

  • Richard B. Lanman

  • Lyudmila Bazhenova

  • Razelle Kurzrock

Medical Centers

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

  • University of California, San Diego, La Jolla, CA

  • University of California, San Diego, Houston, TX

  • Guardant Health, Rewdwood City, CA

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved